Yes. Recognizing the importance of testing within minority populations, vaccine developers worked with community engagement partners to enroll a diverse pool of volunteers in the clinical trials. Thirty-seven percent of volunteers from one manufacturer’s clinical trials alone were from racial and ethnic minority groups.

Here are the racial and ethnic breakdowns of participants in Pfizer and Moderna’s clinical studies Johnson & Johnson’s study also included volunteers from diverse racial and ethnic minority groups:

Pfizer BioNTech:

• Diverse subjects in study: 42%
• Asian: 5%
• Black: 10%
• Hispanic: 26%
• Native American: 1%

Moderna:

• Diverse subjects in study: 31%
• Asian: 4%
• Black: 10%
• Hispanic: 26%
• Native American: 1%

J&J Janssen

• 62.1% White
• 17.2% Black or African American
• 8.3% American Indian or Alaska Native
• 5.4% Multiple races
• 3.5% Asian
• 0.3% Native Hawaiian or other Pacific Islander

Find more information on the demographic breakdowns in each vaccine’s clinical trials on the Vaccine Safety and Monitoring page.